BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Influenza
,
Retina
,
Personalized medicine
,
Tamoxifen
,
rs2476601
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mitogen- activated protein kinase inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
Effects of glucocorticoids and Protein Kinase A on smooth muscle
Antitumor efficacy of GDC-0879 involving BRAF mutational status
Acute monocytic leukemia (AML) THP-1 cells HIV gp120 or LPS stimulated following SB203580 treatment
Embryonic stem cell (ESC)-like cells with Prdm14 knockout treated with LIF-containing serum
NIH-3T3 mouse embryonic fibroblasts expressing RasV12 treated with interferon-alpha or U0126
Explore Curated Studies Results
Literature
Most Relevant Literature
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor.
Histone deacetylase inhibitors suppress mechanical stress-induced expression of RUNX-2 and ADAMTS-5 …
p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U25…
Anti-inflammatory effect and selectivity profile of AS1940477, a novel and potent p38 mitogen-activa…
Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Pro…
P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic P…
Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With…
Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in…
A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Sig…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ